Kura Oncology (KURA) Earnings Date & Reports

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

KURA is expected to report earnings to fall 13.41% to -57 cents per share on July 31

Kura Oncology KURA Stock Earnings Reports

Q2'25

Est.

$-0.57

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.35

Q3'24

Est.

$-0.63

Q2'24

Beat

by $0.04

The last earnings report on May 01 showed earnings per share of -66 cents, missing the estimate of -62 cents. With 742.25K shares outstanding, the current market capitalization sits at 498.67M.

View a ticker or compare two or three

Compare

KURA